THRM trades 35.2% below Wall Street's consensus target of $47.67.
Last 12 months price action with 12-month analyst target path
The base valuation assumes THRM achieves its forward estimates and maintains a stable P/E multiple of 12.1x. This scenario reflects the blended consensus of 15 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 24, 2026, Gentherm Incorporated (THRM) has a Wall Street consensus price target of $47.67, based on estimates from 15 covering analysts. With the stock currently trading at $35.25, this represents a potential upside of +35.2%. The company has a market capitalization of $1.08B.
Analyst price targets range from a low of $34.00 to a high of $59.00, representing a 52% spread in expectations. The median target of $50.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 9 analysts rating the stock as a Buy or Strong Buy,6 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, THRM trades at a trailing P/E of 58.8x and forward P/E of 12.1x. Analysts expect EPS to grow +239.2% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $61.99, with bear and bull scenarios of $39.05 and $81.68 respectively. Model confidence stands at 42/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 MPAAMotorcar Parts of America, Inc. | $200M | $10.56 | $16.00 | +51.5% | Buy | 14.1x | 7 |
 STRTStrattec Security Corporation | $280M | $66.98 | — | — | Hold | 10.8x | 1 |
 DORMDorman Products, Inc. | $3.6B | $121.41 | $165.00 | +35.9% | Buy | 14.0x | 16 |
 NXRTNexPoint Residential Trust, Inc. | $527M | $20.74 | $24.50 | +18.1% | Hold | — | 11 |
 ADNTAdient plc | $1.4B | $17.88 | $28.00 | +56.6% | Buy | 8.8x | 27 |
 LEALear Corporation | $6.2B | $121.69 | $138.67 | +14.0% | Hold | 8.1x | 31 |
 VCVisteon Corporation | $2.5B | $93.03 | $125.86 | +35.3% | Buy | 10.9x | 23 |
 APTVAptiv PLC | $9.6B | $45.17 | $68.90 | +52.5% | Buy | 7.9x | 33 |
 MGAMagna International Inc. | $17.3B | $63.73 | $69.10 | +8.4% | Hold | 9.0x | 30 |
 BWABorgWarner Inc. | $12.4B | $60.55 | $84.33 | +39.3% | Buy | 11.6x | 38 |
Quick answers to the most common questions about buying THRM stock.
The consensus Wall Street price target for THRM is $47.67, representing 35.2% upside from the current price of $35.25. With 15 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
THRM has a consensus rating of "Buy" based on 15 Wall Street analysts. The rating breakdown is predominantly bullish, with 9 Buy/Strong Buy ratings. The consensus 12-month price target of $47.67 implies 35.2% upside from current levels.
With a forward P/E of 12.1439x, THRM trades at a relatively low valuation. The consensus target of $47.67 implies 35.2% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $59 for THRM, while the most conservative target is $34. The consensus of $47.67 represents the median expectation. Our quantitative valuation model projects a bull case target of $82 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
THRM is well covered by analysts, with 15 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 9 have Buy ratings, 6 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month THRM stock forecast based on 15 Wall Street analysts shows a consensus price target of $47.67, with estimates ranging from $34 (bear case) to $59 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $62, with bear/bull scenarios of $39/$82.
Our quantitative valuation model calculates THRM's fair value at $62 (base case), with a bear case of $39 and bull case of $82. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 42/100.
THRM trades at a forward P/E ratio of 12.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 58.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on THRM, with a "Buy" consensus rating and $47.67 price target (35.2% upside). 9 of 15 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
THRM analyst price targets range from $34 to $59, a 52% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $47.67 consensus represents the middle ground. Our model's $39-$82 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.